Specifications - Boehringer Ingelheim Biopharmaceutical Production Facility, Vienna, Austria

Key Data
Order year	2003
Project type	New biopharmaceutical manufacturing facility
Location	Vienna, Austria
Estimated investment	€80 million
Completion	Construction complete in April 2005, validation completed by the end of 2005
Output chemicals	Therapeutic proteins, Plasmid DNA, monoclonal antibodies
Key Players
Sponsor	Boehringer Ingelheim Austria
Designer	Lorenz Consult
Contractors	Bia Separations, M+W Zander
Financing	Boehringer Ingelheim
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems